144 related articles for article (PubMed ID: 21425634)
1. [Classification as carcinogenic for 2,3,7,8-tetrachlorodibenzo-para-dioxin: an eventful journey].
Apostoli P; Bergonzi R; Catalani S
G Ital Med Lav Ergon; 2011; 33(1):84-99. PubMed ID: 21425634
[TBL] [Abstract][Full Text] [Related]
2. [Polychlorinated dibenzofurans and cancer].
Apostoli P; Bergonzi R; Catalani S
G Ital Med Lav Ergon; 2011; 33(2):185-92. PubMed ID: 21796923
[TBL] [Abstract][Full Text] [Related]
3. NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Apr; (521):4-232. PubMed ID: 16835633
[TBL] [Abstract][Full Text] [Related]
4. Human exposure to 2,3,7,8-TCDD and risk of cancer.
Johnson ES
Crit Rev Toxicol; 1991; 21(6):451-63. PubMed ID: 1801848
[TBL] [Abstract][Full Text] [Related]
5. [Chronic exposure to organochlorine compounds and health effects in adults: cancer, non-Hodgkin lymphoma. Review of literature].
Donato F; Zani C
Ann Ig; 2010; 22(4):357-67. PubMed ID: 21425646
[TBL] [Abstract][Full Text] [Related]
6. Cancer mortality in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Fingerhut MA; Halperin WE; Marlow DA; Piacitelli LA; Honchar PA; Sweeney MH; Greife AL; Dill PA; Steenland K; Suruda AJ
N Engl J Med; 1991 Jan; 324(4):212-8. PubMed ID: 1985242
[TBL] [Abstract][Full Text] [Related]
7. Important aspects of the evidence for TCDD carcinogenicity in man.
Johnson ES
Environ Health Perspect; 1993 Mar; 99():383-90. PubMed ID: 8319655
[TBL] [Abstract][Full Text] [Related]
8. An IARC evaluation of polychlorinated dibenzo-p-dioxins and polychlorinated dibenzofurans as risk factors in human carcinogenesis.
McGregor DB; Partensky C; Wilbourn J; Rice JM
Environ Health Perspect; 1998 Apr; 106 Suppl 2(Suppl 2):755-60. PubMed ID: 9599727
[TBL] [Abstract][Full Text] [Related]
9. Dioxin revisited: developments since the 1997 IARC classification of dioxin as a human carcinogen.
Steenland K; Bertazzi P; Baccarelli A; Kogevinas M
Environ Health Perspect; 2004 Sep; 112(13):1265-8. PubMed ID: 15345337
[TBL] [Abstract][Full Text] [Related]
10. Carcinogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in experimental models.
Knerr S; Schrenk D
Mol Nutr Food Res; 2006 Oct; 50(10):897-907. PubMed ID: 16977593
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin: an application of oxidative stress markers to cancer risk assessment of dioxins.
Yoshida R; Ogawa Y
Ind Health; 2000 Jan; 38(1):5-14. PubMed ID: 10680305
[TBL] [Abstract][Full Text] [Related]
12. Oral and dermal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induces cutaneous papillomas and squamous cell carcinomas in female hemizygous Tg.AC transgenic mice.
Wyde ME; Braen AP; Hejtmancik M; Johnson JD; Toft JD; Blake JC; Cooper SD; Mahler J; Vallant M; Bucher JR; Walker NJ
Toxicol Sci; 2004 Nov; 82(1):34-45. PubMed ID: 15282402
[TBL] [Abstract][Full Text] [Related]
13. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) role in hematopoiesis and in hematologic diseases: A critical review.
Fracchiolla NS; Annaloro C; Guidotti F; Fattizzo B; Cortelezzi A
Toxicology; 2016 Dec; 374():60-68. PubMed ID: 27765685
[TBL] [Abstract][Full Text] [Related]
14. Pesticides, soft-tissue sarcoma and non-Hodgkin lymphoma--historical aspects on the precautionary principle in cancer prevention.
Hardell L
Acta Oncol; 2008; 47(3):347-54. PubMed ID: 18347998
[TBL] [Abstract][Full Text] [Related]
15. 2,3,7,8-Tetrachlorodibenzo-p-dioxin mechanistic data and risk assessment: gene regulation, cytotoxicity, enhanced cell proliferation, and tumor promotion.
Whysner J; Williams GM
Pharmacol Ther; 1996; 71(1-2):193-223. PubMed ID: 8910955
[TBL] [Abstract][Full Text] [Related]
16. A critical review of the epidemiology of Agent Orange or 2,3,7,8-tetrachlorodibenzo-p-dioxin and lymphoid malignancies.
Chang ET; Boffetta P; Adami HO; Mandel JS
Ann Epidemiol; 2015 Apr; 25(4):275-292.e30. PubMed ID: 25794766
[TBL] [Abstract][Full Text] [Related]
17. Significant issues raised by meta-analyses of cancer mortality and dioxin exposure.
Starr TB
Environ Health Perspect; 2003 Sep; 111(12):1443-7. PubMed ID: 12948881
[TBL] [Abstract][Full Text] [Related]
18. Long-term effects on humoral immunity among workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
Saberi Hosnijeh F; Boers D; Portengen L; Bueno-de-Mesquita HB; Heederik D; Vermeulen R
Occup Environ Med; 2011 Jun; 68(6):419-24. PubMed ID: 21097950
[TBL] [Abstract][Full Text] [Related]
19. TCDD exposure-response analysis and risk assessment.
Cheng H; Aylward L; Beall C; Starr TB; Brunet RC; Carrier G; Delzell E
Risk Anal; 2006 Aug; 26(4):1059-71. PubMed ID: 16948697
[TBL] [Abstract][Full Text] [Related]
20. Is 2,3,7,8-TCDD (dioxin) a carcinogen for humans?
Ayres SM; Webb KB; Evans RG; Mikes J
Environ Health Perspect; 1985 Oct; 62():329-35. PubMed ID: 3910419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
